Earnings Feed
Start Free
Home/Filings/3/0001209191-18-055459
3//SEC Filing

Hatteras Venture Advisors III, LLC 3

Accession 0001209191-18-055459

CIK 0001169245other
View on SEC.govCompany Profile

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 7:52 PM ET

Size

49.2 KB

Accession

0001209191-18-055459

Insider Transaction Report

Form 3
Period: 2018-10-17
PhaseBio Pharmaceuticals IncPHAS
Hatteras Venture Advisors III, LLC
10% Owner
Holdings

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)
Hatteras Ventures Partners III LP
10% Owner
Holdings

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)
Hatteras Venture Affiliates III Lp
10% Owner
Holdings

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)
LEE KENNETH B JR
10% Owner
Holdings

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)
Reed Douglas MD
10% Owner
Holdings

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)
INGRAM ROBERT ALEXANDER
10% Owner
Holdings

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)
Venture Capital Multiplier Fund
10% Owner
Holdings

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)
Crumpler John
10% Owner
Holdings

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)
Catalysta Ventures, LLC
10% Owner
Holdings

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)
Hatteras Venture Partners I, LP
10% Owner
Holdings

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners I, LP)
    → Common Stock (52,690 underlying)

  • Series 1 Preferred Stock

    (indirect: By LLC)
    → Common Stock (4,846 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (718 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (47,458 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    Exercise: $0.12→ Series C-1 Preferred Stock (41,414 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (9,353 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $9.66Exp: 2019-12-22→ Series B Preferred Stock (7,910 underlying)

  • Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (103,001 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (272,107 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series B Preferred Stock (1,731 underlying)

  • Warrants to Purchase Series C-1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    Exercise: $0.12→ Series C-1 Preferred Stock (4,309 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (3,862 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (1,026,161 underlying)

  • Series B Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (93,185 underlying)

  • Series D Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (24,709 underlying)

  • Series D Preferred Stock

    (indirect: By Venture Capital Multiplier Fund)
    → Common Stock (226,061 underlying)

  • Series 1 Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (42,530 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    → Common Stock (174,699 underlying)

  • Series AA Preferred Stock

    (indirect: By Hatteras Venture Affiliates III, LP)
    → Common Stock (13,609 underlying)

  • Warrants to Purchase Series B Preferred Stock

    (indirect: By Hatteras Venture Partners III, LP)
    Exercise: $0.12→ Series B Preferred Stock (19,061 underlying)
Footnotes (5)
  • [F1]Each share of Preferred Stock is convertible at any time at the option of the holder into Common Stock, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
  • [F2]Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.
  • [F3]HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately.
  • [F4]Immediately exercisable.
  • [F5]The warrants terminate upon the closing of the Issuer's initial public offering.

Documents

2 files

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

→
Entity typeother
IncorporatedNC

Related Parties

1
  • filerCIK 0001674177

Filing Metadata

Form type
3
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 7:52 PM ET
Size
49.2 KB
View on SEC.gov